The estradiol pharmacophore: Ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site
Tóm tắt
Từ khóa
Tài liệu tham khảo
Belchetz, 1994, Drug therapy: Hormonal treatment of postmenopausal women, N Engl J Med, 330, 1062, 10.1056/NEJM199404143301508
Simonsen, 1994, Top 200 drugs of 1993: Price of average Rx up only 2.9%, Pharm Times, April, 18
Fevig, 1987, A short, stereoselective route to 16α-(substituted-alkyl)estradiol derivatives, J Org Chem, 52, 247, 10.1021/jo00378a015
Katzenellenbogen, 1988, Affinity labeling studies of estrogen receptors, 87
Katzenellenbogen, 1987, Cytotoxic oestrogens and antioestrogens: Concepts, progress, and evaluation, 41
Cummins, 1993, Radiolabeled steroidal estrogens in cancer research, Steroids, 58, 245, 10.1016/0039-128X(93)90069-Y
von Angerer, 1995
Evans, 1988, The steroid and thyroid hormone receptor superfamily, Science, 240, 889, 10.1126/science.3283939
Green, 1991, The oestrogen receptor: from perception to mechanism, 15
Gronemeyer, 1995, Transcription Factors 3: Nuclear Receptors, Vol. 2, 1173
Zeelen, 1990
Pakdel, 1990, Full-length sequence and in vitro expression of rainbow trout estrogen receptor cDNA, Mol Cell Endocrinol, 71, 195, 10.1016/0303-7207(90)90025-4
Koike, 1987, Molecular cloning and characterization of rat estrogen receptor cDNA, Nucleic Acids Res, 15, 2499, 10.1093/nar/15.6.2499
White, 1987, Structural organization and expression of the mouse estrogen receptor, Mol Endocrinol, 1, 735, 10.1210/mend-1-10-735
Green, 1986, Human oestrogen receptor cDNA: Sequence, expression and homology to v-erb-A, Nature, 320, 134, 10.1038/320134a0
Greene, 1986, Sequence and expression of human estrogen receptor complementary DNA, Science, 231, 1150, 10.1126/science.3753802
Krust, 1986, The chicken oestrogen receptor sequence: Homology with v-erbA and the human oestrogen and glucocorticoid receptors, EMBO J, 5, 891, 10.1002/j.1460-2075.1986.tb04300.x
Bökenkamp, 1994, The C-terminal half of the porcine estradiol receptor contains no post-translational modification: determination of the primary structure, Mol Cell Endocrinol, 104, 163, 10.1016/0303-7207(94)90119-8
Schwabe, 1993, DNA recognition by the oestrogen receptor: From solution to the crystal, Structure, 1, 187, 10.1016/0969-2126(93)90020-H
Bourguet, 1995, Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α, Nature, 375, 377, 10.1038/375377a0
Renaud, 1995, Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid, Nature, 378, 681, 10.1038/378681a0
Wagner, 1995, A structural role for hormone in the thyroid hormone receptor, Nature, 378, 690, 10.1038/378690a0
Wurtz, 1996, A canonical structure for the ligand-binding domain of nuclear receptors, Nature Struct Biol, 3, 87, 10.1038/nsb0196-87
Katzenellenbogen, 1996, Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones, Mol Endocrinol, 10, 119, 10.1210/me.10.2.119
Katzenellenbogen, 1996, Nuclear hormone receptors: Ligand-activated regulators of transcription and diverse cell responses, Chem Biol, 3, 529, 10.1016/S1074-5521(96)90143-X
Anstead, 1995, Predicted carcinogenicity and structure-estrogen receptor binding affinities of benz[a]anthracene diols, Steroids, 60, 383, 10.1016/0039-128X(94)00070-S
Murphy, 1992, Thermodynamics of structural stability and cooperative folding behavior in proteins, Adv Protein Chem, 43, 313, 10.1016/S0065-3233(08)60556-2
Testa, 1987, Do thermodynamic studies provide information on both the binding to and the activation of dopaminergic and other receptors?, Biochem Pharmacol, 23, 4041, 10.1016/0006-2952(87)90559-4
Katzenellenbogen, 1982, In vivo and in vitro steroid receptor assays in the design of estrogen pharmaceuticals, Vol. I, 93
Pomper, 1990, 11β-Methoxy, 11β-ethyl, and 17α-ethynyl-substituted 16α-fluoroestradiols: Receptor-based imaging agents with enhanced uptake efficiency and selectivity, J Med Chem, 33, 3143, 10.1021/jm00174a009
Hospital, 1972, X-ray crystallography of estrogens and their binding to receptor sites, Molec Pharmacol, 8, 438
Anstead, 1990, Torsionally- and hydrophobically modified 2,3-diarylindenes as estrogen receptor ligands, J Med Chem, 33, 2726, 10.1021/jm00172a008
Weeks, 1970, The crystal and molecular structure of diethylstilbestrol, Acta Crystallog, B26, 429, 10.1107/S0567740870002509
Duax, 1985, Molecular conformation, receptor binding, and hormone action of natural and synthetic estrogens and antiestrogens, Environ Health Perspect, 61, 111, 10.1289/ehp.8561111
Dewar, 1985, AMl: A new general purpose quantum mechanical molecular model, J Am Chem Soc, 107, 3902, 10.1021/ja00299a024
Duax, 1980, Molecular basis of estrogenicity: X-ray crystallographic studies, 11
Wiese, 1994, Molecular modeling of steroidal estrogens: Novel conformations and their role in biological activity, J Steroid Biochem Molec Bio, 50, 61, 10.1016/0960-0760(94)90173-2
Andrews, 1984, Functional group contributions to drug-receptor interactions, J Med Chem, 27, 1648, 10.1021/jm00378a021
Arányi, 1980, Kinetics of the hormone-receptor interaction, Biochim Biophys Acta, 628, 220, 10.1016/0304-4165(80)90369-4
Bouton, 1978, The relevance of kinetic parameters in determination of specific binding to the estrogen receptor, J Steroid Biochem, 9, 9, 10.1016/0022-4731(78)90094-8
Bindal, 1987, 11β-Chloromethyl-[3H]estradiol-17β: A very high-affinity, reversible ligand for the estrogen receptor, J Steroid Biochem, 28, 361, 10.1016/0022-4731(87)91052-1
Salomonsson, 1994, Equilibrium hormone binding to human estrogen receptors in highly diluted cell extracts is noncooperative and has a Kd of approximately 10 pM, J Steroid Biochem Molec Biol, 50, 313, 10.1016/0960-0760(94)90137-6
Sanborn, 1971, Interaction of 17β-estradiol and its specific uterine receptor, Biochemistry, 26, 4955, 10.1021/bi00802a019
King, 1974, Steroid-Cell Interactions, 192
Eckert, 1982, Physical properties of estrogen receptor complexes in MCF-7 human breast cancer cells, J Biol Chem, 257, 8840, 10.1016/S0021-9258(18)34206-6
Vollmer, 1991, Methyl and bromo derivatives of estradiol are agonistic ligands for the estrogen receptor of MCF-7 breast cancer cells, J Steroid Biochem Molec Biol, 39, 359, 10.1016/0960-0760(91)90047-9
Lövgren, 1978, Binding characteristics of estrone, estradiol, and estriol to the human myometrial receptor, J Steroid Biochem, 9, 803, 10.1016/0022-4731(78)90204-2
Ratajczak, 1981, The synthesis and study of some potential affinity labeling reagents for estrogen receptors, Steroids, 38, 537, 10.1016/0039-128X(81)90053-2
Fanchenko, 1979, The specificity of the human estrogen receptor, Acta Endocrin (Copenh), 90, 167, 10.1530/acta.0.0900167
Daniellian, 1993, Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen, Molec Endocrin, 7, 232, 10.1210/me.7.2.232
Kuiper, 1996, Cloning of a novel receptor expressed in rat prostate and ovary, 93, 5925
Keasling, 1950, The relationship between estrogenic action and chemical constitution in a group of azomethine derivatives, J Am Pharm Assoc, 39, 87, 10.1002/jps.3030390209
Ojasoo, 1995, Correspondence factor analysis of steroid libraries, Steroids, 60, 458, 10.1016/0039-128X(95)00005-B
Delettré, 1980, Steroid flexibility and receptor specificity, J Steroid Biochem, 13, 45, 10.1016/0022-4731(80)90112-0
Raynaud, 1985, Structure-activity relationships of steroidal estrogens, II, 24
Baker, 1984, Hydrogen bonding in globular proteins, Prog Biophys Molec Biol, 44, 97, 10.1016/0079-6107(84)90007-5
Cooper, 1969, Estrogenic steroids. III. The crystal and molecular structure of estriol, Acta Crystallog, B25, 814, 10.1107/S0567740869003098
Chernayaev, 1975, A series of optical, structural and isomeric analogs of estraidol: A comparative study of the biological activity and affinity to cytosol receptor of rabbit uterus, J Steroid Biochem, 6, 1483, 10.1016/0022-4731(75)90201-0
Schwartz, 1993, Ligand-mediated modulation of estrogen receptor conformation by estradiol analogs, Biochemistry, 32, 10,109, 10.1021/bi00089a029
Anstead, 1989, 2-Arylindenes and 2-arylindenones: Molecular structures and considerations in the binding orientation of unsymmetrical nonsteroidal ligands to the estrogen receptor, J Med Chem, 32, 2163, 10.1021/jm00129a024
Brooks, 1987, Estrogen structure-receptor function relationships, 443
Busetta, 1972, Structure cristalline et moléculaire de l'oestradiol hemihydrate, Acta Crystallog, C43, 1206
Busetta, 1972, Structure cristalline et moléculaire du complexe oestradiol-propanol, Acta Crystallog, B28, 1349, 10.1107/S0567740872004285
Duax, 1972, The structure of the crystalline complex estradiol urea (1:1), Acta Crystallog, B28, 1864, 10.1107/S0567740872005151
Legrand, 1961, Effet à distance en série stéroïde. II. Influence des fonctions en 17 sur le pK des stéroïdes phénoliques, Bull Soc Chim France, 1346
Eik-Nes, 1954, The binding of steroids to proteins. I. Solubility determinations, J Biol Chem, 206, 411, 10.1016/S0021-9258(18)71331-8
Abraham, 1989, Hydrogen bonding. Part 9. Solute proton donor and proton acceptor scales for use in drug design, J Chem Soc Perkin Trans II, 1355, 10.1039/p29890001355
Fersht, 1985, Hydrogen bonding and biological specificity analyzed by protein engineering, Nature, 314, 235, 10.1038/314235a0
Feller, 1993, Ab initio study of hydrogen bonding in the phenol-water system, J Comp Chem, 14, 1027, 10.1002/jcc.540140904
Kollman, 1973, Quantitation of long-range effects in steroids by molecular orbital calculations, J Am Chem Soc, 95, 2869, 10.1021/ja00790a022
Azzi, 1996, Crystal structure of human estrogenic 17β-hydroxysteroid dehydrogenase complexed with 17β-estradiol, Nature Struct Biol, 3, 665, 10.1038/nsb0896-665
Breton, 1996, The structure of a complex of human 17β-hydroxysteroid dehydrogenase with estradiol adn NADP+ identifies two principal targets for the design of inhibitors, Structures, 4, 905, 10.1016/S0969-2126(96)00098-6
Gabbard, 1983, Structure-activity relationships of estrogens, Steroids, 41, 791, 10.1016/0039-128X(83)90054-5
Korenman, 1969, Comparative binding affinity of estrogens and its relation to estrogenic potency, Steroids, 13, 163, 10.1016/0039-128X(69)90004-X
Katzenellenbogen, 1973, Photoaffinity labels for estrogen binding proteins of rat uterus, Biochemistry, 12, 4085, 10.1021/bi00745a010
Martin, 1979, Advances in the methodology of quantitative drug design, Drug Design, VIII, 1, 10.1016/B978-0-12-060308-4.50007-X
Purdy, 1985, Does estrogen-induced genotoxicity require receptor-mediated events?, II, 146
Delettré, 1980, An approach to the mapping of the steroid hormone receptor, 1
Ippolito, 1990, Hydrogen bond stereochemistry in protein structure and function, J Mol Biol, 215, 457, 10.1016/S0022-2836(05)80364-X
Thanki, 1988, Distribution of water around amino acid residues in proteins, J Mol Biol, 202, 637, 10.1016/0022-2836(88)90292-6
Antypas, 1981, Restricted rotation in hydroxyphenyl ketones and formaldehydes, J Org Chem, 46, 1172, 10.1021/jo00319a025
Duax, 1981, Molecular details of receptor binding and hormonal action of steroids derived from X-ray crystallographic investigations, J Steroid Biochem, 15, 41, 10.1016/0022-4731(81)90256-9
Weber, 1972, The crystal and molecular structures of an unusual estrasteroid and its dihydroproduct, Helv Chem Acta, 55, 544, 10.1002/hlca.19720550226
Sampson, 1992, Segmental motion in catalysis: Investigation of a hydrogen bond critical for loop closure in the reaction of triosephosphate isomerase, Biochemistry, 31, 8488, 10.1021/bi00151a015
Rupley, 1991, Protein hydration and function, Adv Protein Chem, 41, 37, 10.1016/S0065-3233(08)60197-7
Busetta, 1977, Some hypotheses about interactions between estrogen and androgen and their possible receptors, J Steroid Biochem, 8, 63, 10.1016/0022-4731(77)90218-7
Tsukuda, 1968, The crystal and molecular structure of oestradiol 3-p-bromobenzoate, J Chem Soc B, 1387, 10.1039/j29680001387
Reck, 1986, Crystal and molecular structure of 3-methoxy-estra-1,3,5(10)-triene-17β-ol, Cryst Res Tech, 21, 1313, 10.1002/crat.2170211014
Go, 1982, Structure of 4-fluoro-1,3,5(10)-estratriene-3,17β-diol-hemimethanol, Acta Crystallog, B38, 3142, 10.1107/S0567740882011121
Norton, 1964, The crystal and molecular structure of 4-bromoestradiol, Acta Crystallog, 17, 77, 10.1107/S0365110X64000299
Busetta, 1976, 1,3,5(10)-Oestradiol-3,17α-diol, Acta Crystallog, B32, 1290, 10.1107/S0567740876005177
Meyer, 1992, Internal water molecules and H-bonding in biological macromolecules: A review of structural features with functional implications, Protein Sci, 1, 1543, 10.1002/pro.5560011203
Chan, 1992, Ligand atom partial charges assignment for complementary electrostatic potentials, J Comp-Aided Molec Deisgn, 6, 461, 10.1007/BF00130397
Rashin, 1986, Internal cavities and buried waters in globular proteins, Biochemistry, 25, 3619, 10.1021/bi00360a021
Matthews, 1995, Use of NMR to detect water within nonpolar protein cavities, Science, 270, 1847, 10.1126/science.270.5243.1847
Wade, 1993, Further development of hydrogen bond functions for use in determining energetically favorable binding sites on molecules of known structure. 1. Ligand probe groups with the ability to form two hydrogen bonds, J Med Chem, 36, 140, 10.1021/jm00053a018
Ben-Naim, 1990, Solvent effects on binding thermodynamics of biopolymers, Biopolymers, 29, 901, 10.1002/bip.360290604
Raynaud, 1979, Receptor binding as a tool in the development of bioactive steroids, Drug Design, VIII, 169, 10.1016/B978-0-12-060308-4.50010-X
Fritsch, 1992, A ligand-induced conformational change in the estrogen receptor is localized to the steroid binding domain, Biochemistry, 31, 5303, 10.1021/bi00138a009
Mornon, 1977, Interactions of hormonal steroids: Progestogens, J Steroid Biochem, 8, 51, 10.1016/0022-4731(77)90217-5
Schmit, 1980, The androgen receptor binding site: Conformational study of steroids in relation with their affinity. I. Interactions with the D-ring, J Steroid Biochem, 13, 1387, 10.1016/0022-4731(80)90048-5
Kaspar, 1985, Shielding effects at 17α-substituted estrogens, J Steroid Biochem, 23, 611, 10.1016/0022-4731(85)90012-3
Boobbyer, 1989, New hydrogen-bond potentials for use in determining energetically favorable binding sites on molecules of known structure, J Med Chem, 32, 1083, 10.1021/jm00125a025
DesJarlais, 1986, Docking flexible ligands to macromolecular receptors by molecular shape, J Med Chem, 29, 2149, 10.1021/jm00161a004
Ye, 1993, Synthesis of new amino acid and peptide derivatives of estradiol and their binding affinities for the estrogen receptor, Steroids, 58, 35, 10.1016/0039-128X(93)90015-F
Kaspar, 1985, Steroid binding to the cytosolic estrogen receptor from rat uterus, J Steroid Biochem, 23, 259, 10.1016/0022-4731(85)90403-0
Ouellet, 1984, Synthesis, receptor binding, and target-tissue uptake of carbon-11 labeled carbamate derivatives of estradiol and hexestrol, J Med Chem, 27, 509, 10.1021/jm00370a013
Huheey, 1978, Inorganic chemistry: Principles of Structure and Reactivity, 267
Merriam, 1980, 2-Hydroxyestradiol-17α and 4-hydroxyestradiol 17α, catechol estrogens with reduced estrogen receptor binding affinity, Steroids, 36, 13, 10.1016/0039-128X(80)90063-X
Vander Kuur, 1993, Influence of estrogen structure on nuclear binding and progesterone receptor induction by the receptor complex, Biochemistry, 32, 7002, 10.1021/bi00078a027
Shutt, 1972, Steroid and phyto-oestrogen binding to sheep uterine receptors in vitro, J Endocrinol, 52, 299, 10.1677/joe.0.0520299
Hähnel, 1973, The specificity of the estrogen receptor of human uterus, J Steroid Biochem, 4, 21, 10.1016/0022-4731(73)90076-9
Gabbard, 1983, Structure-activity relationships of 9β-estrogens, Steroids, 42, 555, 10.1016/0039-128X(83)90119-8
Müller, 1977, Post-coital contraceptive activity and estrogen receptor binding affinity of phenolic steroids, Endocrinology, 100, 513, 10.1210/endo-100-2-513
Martucci, 1976, Uterine estrogen receptor binding of catecholestrogens and estetrol (1,3,5(10)-estratriene-3,15α,16α,17β-tetrol), Steroids, 27, 325, 10.1016/0039-128X(76)90054-4
Lee, 1977, Coumestrol, NBD-norhexestrol, dansyl-norhexestrol, fluorescent probes of estrogen-binding proteins, Biochemistry, 16, 2896, 10.1021/bi00632a015
Katzenellenbogen, 1974, Photoreactivity of some light-sensitive estrogen derivatives, Biochemistry, 13, 2986, 10.1021/bi00711a031
Dandliker, 1978, Investigation of hormone-receptor interactions by means of fluorescent labeling, Cancer Res, 38, 4212
Ali, 1991, Synthesis and receptor binding affinity of 7α- and 17α-substituted 2- and 4-chloroestradiol derivatives, J Chem Soc Perkin, I, 2485, 10.1039/P19910002485
Swaneck, 1988, Covalent binding of the endogenous estrogen 16α-hydroxyestrone to estradiol receptor in human breast cancer cells: Characterization and intranuclear localization, 85, 7831
Salman, 1986, 17α-Allyl estradiol analogues as candidates for development of high-affinity fluorescein-estradiol conjugates, J Steroid Biochem, 24, 539, 10.1016/0022-4731(86)90117-2
Salman, 1991, 17α-Substituted analogs of estradiol for the development of fluorescent estrogen receptor ligands, Steroids, 56, 375, 10.1016/0039-128X(91)90070-C
Gale, 1971, The solubilisation of steroids by lysophosphatidylcholine: Testosterone, estradiol, and their 17α-ethinyl derivatives, Biochim Biophys Acta, 248, 466, 10.1016/0005-2760(71)90236-0
Moriguchi, 1976, van der Waals volume and the related parameters for hydrophobicity in structure-activity studies, Chem Pharm Bull, 24, 1799, 10.1248/cpb.24.1799
El Garrouj, 1993, Steroidal affinity labels of the estrogen receptor. 1. 17α-(Bromoacetoxy)alkyl/alkynyl estradiols, J Med Chem, 36, 2973, 10.1021/jm00072a018
Napolitano, 1991, Structure-activity relationships of estrogenic ligands: Synthesis and evaluation of (17α,20E)- and (17α,20Z)-21-halo-19-norpregnal-1,3,5(10),20-tetraene-3,17β-diols, J Med Chem, 34, 2754, 10.1021/jm00113a012
Napolitano, 1996, Synthesis and estrogen receptor binding of (17α,20E)- and (17α,20Z)-21-phenythio- and 21-phenylseleno-19-norpregna-1,3,5(10),20-tetraene-3,17β-diols, Steroids, 61, 384, 10.1016/0039-128X(96)00045-1
Ali, 1988, Synthesis, receptor binding, and tissue distribution of (17α,20E)- and (17α,20Z)-21-[125I]Iodo-19-norpregna-1,3,5(10),20-tetraene-3,17-diol, J Med Chem, 31, 1946, 10.1021/jm00118a013
Napolitano, 1995, 11β-Substituted estradiol derivatives, potential high-affinity carbon-11-labeled probes for the estrogen receptor: A structure-affinity study, J Med Chem, 38, 429, 10.1021/jm00003a005
Ali, 1993, Synthesis, receptor binding, and biodistribution of the gem-21-chloro-21-iodovinylestradiol derivatives, J Steroid Biochem Molec Biol, 46, 613, 10.1016/0960-0760(93)90189-4
Mazaitis, 1980, Radioiodinated estrogen derivatives, J Nucl Med, 21, 142
Arunachalam, 1979, Iodoestrogens, syntheses, and interaction with uterine receptors, J Biol Chem, 254, 5900, 10.1016/S0021-9258(18)50499-3
Hansch, 1995, Exploring QSAR, 515
Hörhold, 1975, Strucktur-Stoffwechel-Wirkungsbeziehungen bei 17α-CH2X-substituierten Östra-1,3,5(10)-trienenen, Pharmazie, 30, 35
Jaouen, 1993, Bioorganometallic chemistry: A future direction for transition metal organometallic chemistry?, Acc Chem Res, 26, 361, 10.1021/ar00031a002
Vessières, 1989, Organometallic derivatives of estradiol as bioligands: Targetted binding of the estradiol receptor, J Steroid Biochem, 34, 301, 10.1016/0022-4731(89)90097-6
El Amouri, 1992, Synthesis and affinities of novel organometallic-labeled estradiol derivatives: a structure-affinity relationship, J Med Chem, 35, 3130, 10.1021/jm00095a006
Sadek, 1982, Selenium labeling in nuclear medicine. 2. D-ring substituted estrogens, J Med Chem, 25, 1488, 10.1021/jm00354a019
Lam, 1987, Estrogen receptor-binding affinity and cytotoxic activity of three new estrogen-nitrosourea conjugates in human breast cancer cell lines in vitro, Cancer Treat Rept, 71, 901
Delbarre, 1985, Ellipticine derivatives with an affinity to the estrogen receptor, J Med Chem, 28, 752, 10.1021/jm00383a011
Gill, 1986, 3,17β-Dihydroxy-20,21-epoxy-19-norpregna-1,3,5(10)-trienes: synthesis, rearrangement, cytotoxicity, and estrogen-receptor binding, J Med Chem, 29, 1537, 10.1021/jm00158a039
El Garrouj, 1995, Steroidal affinity labels of the estrogen receptor. 2. 17α-[(haloacetamido)alkyl]estradiols, J Med Chem, 38, 2339, 10.1021/jm00013a011
Zeelen, 1980, 39
Hähnel, 1974, The steroid specificity of the estrogen receptor of human breast carcinoma, J Steroid Biochem, 5, 119, 10.1016/0022-4731(74)90117-4
Hylarides, 1988, Structural comparison of 1-bromo- and 1-fluoroestradiol with D-estradiol, Acta Crystallog, C44, 709
Heiman, 1980, Estrogen receptor based imaging agents. 1. Synthesis and receptor binding affinity of some aromatic and D-ring halogenated estrogens, J Med Chem, 23, 994, 10.1021/jm00183a007
Mukawa, 1988, Estrogen and androgen receptor binding affinity of 10β-chloro-estrenen derivatives, J Steroid Biochem, 31, 867, 10.1016/0022-4731(88)90298-1
Katzenellenbogen, 1980, The chemistry of estrogens and antiestrogens: Relationships between structure, receptor binding, and biological activity, 33
Chesne, 1986, Synthesis and biological studies of aminoestradiol-platinum (II) conjugates, Eur J Med Chem, 21, 321
Cushman, 1995, Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site, J Med Chem, 38, 2041, 10.1021/jm00012a003
Qian, 1990, Synthesis and biological activity of 4-methylestradio, J Steroid Biochem, 35, 745, 10.1016/0022-4731(90)90318-M
Charton, 1971, The quantitative treatment of the ortho effect, Prog Phys Org Chem, 8, 235, 10.1002/9780470171875.ch3
Egorova, 1973, Structure and reactivity of steroids—VI: Long-range effects in a series of Δ1,3,5(10) estratriene compounds, Tetrahedron, 29, 301, 10.1016/S0040-4020(01)93294-6
1992, 7
1992, 8
Honig, 1995, Classical electrostatics in biology and chemistry, Science, 268, 1144, 10.1126/science.7761829
Rochester, 1971, Acidity and inter- and intra-molecular Hbonds, 327
Dietrich, 1976, A theoretical study of intramolecular hydrogen bonding in ortho-substituted phenols and thiophenols, J Am Chem Soc, 98, 8310, 10.1021/ja00442a002
Baker, 1958, On the cis-trans equilibria in o-halophenols, J Am Chem Soc, 80, 3598, 10.1021/ja01547a028
Palomino, 1990, Binding, X-ray, and NMR studies of the three A-ring isomers of natural estradio, J Steroid Biochem, 35, 219, 10.1016/0022-4731(90)90278-Z
Napolitano, 1990, Estrogen receptor binding characteristics of 1,11β-ethanoestradiol: Effect of a 1,11β bridge on steroidal estrogen, J Steroid Biochem Molec Biol, 37, 295, 10.1016/0960-0760(90)90341-H
Ali, 1993, 2- and 4-Fluorinated 16α-[125I]iodoestradiol derivatives: Synthesis and effect on estrogen receptor binding and receptor-mediated target tissue uptake, J Med Chem, 36, 4255, 10.1021/jm00078a016
Bucort, 1978, New biospecific adsorbents for the purification of estradiol receptor, J Biol Chem, 253, 8221, 10.1016/S0021-9258(17)34385-5
Vessières, 1988, Organometallic estrogens: Synthesis, interaction with lamb uterine estrogen receptor, and detection by infrared spectroscopy, Biochemistry, 27, 6659, 10.1021/bi00418a003
DiZio, 1992, Estrogen platinum-diamine complexes: Preparation of a nonsteroidal estrogen platinum-diamine complex labeled with platinum-191 and a study of its binding to the estrogen receptor in vitro and its tissue distribution in vivo, J Steroid Biochem Mol Biol, 42, 363, 10.1016/0960-0760(92)90141-5
Van Aswegen, 1989, Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancer, J Steroid Biochem, 32, 485, 10.1016/0022-4731(89)90380-4
Martucci, 1979, Impact of continuously administered catechol estrogens on uterine growth and lutenizing hormone secretion, Endocrinology, 105, 1288, 10.1210/endo-105-6-1288
Wawrzak, 1988, Steroid structure and function, J Steroid Biochem, 29, 387, 10.1016/0022-4731(88)90247-6
Canceill, 1983, Substituted derivatives of A-nor-5α-androstane and A-nor-5α-estrane-structure and affinity for hormonal receptors, J Steroid Biochem, 18, 643, 10.1016/0022-4731(83)90241-8
Duax, 1984, Steroid hormone action interpreted from X-ray crystallographic studies, Vol. XI, 187
Burley, 1988, Weakly polar interactions in proteins, Adv Protein Chem, 39, 125, 10.1016/S0065-3233(08)60376-9
Dougherty, 1996, Cation-π interactions in chemistry and biology: A new view of benzene, phe, tyr, and trp, Science, 271, 163, 10.1126/science.271.5246.163
Doukas, 1975, The role of charge-transfer processes in the action of bioactive materials, Drug Design, V, 133, 10.1016/B978-0-12-060305-3.50009-6
Mauchamp, 1969, The nature of thyroxine and related compounds as electron donors, Biochemistry, 8, 1554, 10.1021/bi00832a034
Kearney, 1993, Molecular recognition in aqueous media, J Am Chem Soc, 115, 9907, 10.1021/ja00075a006
Bélanger, 1981, Regio- and stereospecific synthesis of 11β-substituted 19-norsteroids, Steroids, 37, 361, 10.1016/0039-128X(81)90039-8
Napolitano, 1995, 11β-Substituted estradiol derivatives. 2. Potential carbon-11 and iodine-labeled probes for the estrogen receptor, J Med Chem, 38, 2774, 10.1021/jm00014a028
Palomino, 1994, Skeletal conformations and receptor binding of some 9,11-modified estradiols, J Steroid Biochem Molec Biol, 50, 75, 10.1016/0960-0760(94)90174-0
Qian, 1990, Synthesis and biological activities of 11β-substituted estradiol as potential antiestrogens, Steroids, 55, 238, 10.1016/0039-128X(90)90022-4
Schönemann, 1980, Potential antitumor agents: 11β-(1-aziridinylmethyl) derivatives of œstradiol and œstrone, Eur J Med Chem, 15, 333
Nique, 1994, 11β-Amidoalkoxyphenyl estradiols, J Steroid Biochem Molec Biol, 50, 21, 10.1016/0960-0760(94)90168-6
Fevig, 1988, Estrogen receptor binding tolerance of 16α-substituted estradiol derivatives, Steroids, 51, 471, 10.1016/0039-128X(88)90046-3
Hochberg, 1980, Interaction of 16α-[125I]iodoestradiol with estrogen receptor and other steroid-binding proteins, 77, 328
Hochberg, 1986, The molecular structure of 16α-iodo-17β-estradiol, a high affinity ligand for the estrogen receptor, J Steroid Biochem, 25, 615, 10.1016/0022-4731(86)90002-6
Van Brocklin, 1994, The synthesis of 7α-methyl-substituted estrogens labeled with fluorine-18: Potential breast tumor imaging agents, Steroids, 59, 34, 10.1016/0039-128X(94)90043-4
Ponsold, 1977, Quantitative Struktur-Wirkungs-Beziehungen zwischen physikochemischen Paramentern 16α-heterosubstituierter Östradiole und dem Bindungsvermögen an Rezeptoren des Rattenuterus in vitro, Pharmazie, 32, 596
Redeuilh, 1985, The use of biotinyl estradiol-avidin system for the purification of “nontransformed” estrogen receptor by biohormonal affinity chromatography, J Biol Chem, 260, 3996, 10.1016/S0021-9258(18)89221-3
French, 1993, A synthesis of 7α-substituted estradiols: Synthesis and biological evaluation of 7α-pentyl-substituted BODIPY fluorescent conjugate and a fluorine-18-labeled 7α-pentylestradiol analog, Steroids, 58, 157, 10.1016/0039-128X(93)90063-S
Mühlenbruch, 1986, Synthese und Eigenschaften fluoreszierender Estradiol-Derivate, Arch Pharm (Weinheim), 319, 196, 10.1002/ardp.19863190303
DaSilva, 1990, Synthesis and structure-affinity of a series of 7α-undecylestradiol derivatives: A potential vector for therapy and imaging of estrogen-receptor-positive cancers, J Med Chem, 33, 430, 10.1021/jm00163a066
Weatherill, 1988, Interaction of the antioestrogen ICI 164,384 with the oestrogen receptor, J Steroid Biochem, 30, 263, 10.1016/0022-4731(88)90103-3
Wakeling, 1992, ICI 182,780, a new antioestrogen with clinical potential, J Steroid Biochem, 43, 173, 10.1016/0960-0760(92)90204-V
Katzenellenbogen, 1976, Chemical probes of estrogen action: Affinity labeling, J Toxicol Environ Health, 205
Blinkenstaff, 1980, Estrogen-Catharanthus (Vinca) alkaloid conjugates, 89
Joyce, 1982, Studies with steroid-fluorescein conjugates on estrogen target tissues, Eur J Clin Oncol, 18, 1147, 10.1016/0277-5379(82)90096-7
Duax, 1981, Steroid structure and function-IX. Molecular conformation and receptor binding of isometric analogs of D-homo-estradiol, J. Steroid Biochem, 14, 1, 10.1016/0022-4731(81)90185-0
Bohl, 1987, Quantitative structure-activity relationships of estrogenic steroids substituted at C14,C15, J Steroid Biochem, 26, 589, 10.1016/0022-4731(87)90012-4
Rekker, 1992, Calculation of Drug Lipophilicity: The Hydrophobic Fragmental Constant Approach, 77
Westphal, 1971, Steroid-Protein Interactions, 108
Eriksson, 1992, Response of protein structure to cavity-creating mutations and its relation to the hydrophobic effect, Science, 255, 178, 10.1126/science.1553543
Dewar, 1984, A new procedure for calculating molecular polarizabilities: Applications using MNDO, Chem Phys Lett, 111, 416, 10.1016/0009-2614(84)85532-3
Honig, 1993, Macroscopic models of aqueous solutions: Biological and chemical applications, J Phys Chem, 97, 1101, 10.1021/j100108a002
Smithrud, 1990, Strength of molecular complexation of apolar solutes in water and organic solvents is predictable by linear free-energy relationships: A general model for solvation effects on apolar binding, J Am Chem Soc, 112, 339, 10.1021/ja00157a052
Bohl, 1992, Molecular Structure and Biological Activity of Steroids, 144
Mueller, 1978, Displacement from estrogen receptors by simple alkyl phenols, Endocrinology (Baltimore), 102, 1429, 10.1210/endo-102-5-1429
Marshall, 1987, Computer-aided drug design, Ann Rev Pharmacol Toxicol, 27, 193, 10.1146/annurev.pa.27.040187.001205
Durani, 1979, Seco-oestradiols and some nonsteroidal oestrogens: Structural correlates of oestrogenic action, J Steroid Biochem, 11, 67, 10.1016/0022-4731(79)90278-4
Rosen, 1980, Synthesis and biological activity of 15-oxaestranes, J Med Chem, 23, 329, 10.1021/jm00177a026
Simon, 1984, Structure-binding affinity correlations for iodo- and selenoestrogen analogs and mapping of the estrogen receptor by the MTD-method, Rev Roum Chem, 29, 83
Ikeda, 1982, Identification of thiol group at the estrogen binding site on the cytoplasmic receptor from rabbit uterus by affinity labeling, Biochiom Biophys Acta, 718, 66, 10.1016/0304-4165(82)90010-1
Fitch, 1990, A new structure for the low-temperature phase of solid hydrogen sulphide, J Chem Soc Chem Comm, 515, 10.1039/c39900000515
Rosei, 1988, SH vibrational frequency and hydrogen bond in biological thiols: A critical analysis, Physiol Chem Phys Med NMR, 20, 189
Paul, 1974, Structural chemistry of the thiol group, 111
Simons, 1987, Identification of cysteine 656 as the amino acid of hepatoma tissue culture cell glucocorticoid receptors that is covalently labeled by dexamethasone 21-mesylate, J Biol Chem, 262, 9676, 10.1016/S0021-9258(18)47987-2
Reese, 1992, Identification of two cysteines closely positioned in the lignad-binding pocket of the human estrogen receptor: Roles in ligand binding and transcriptional activation, Molec Endocrinol, 6, 2160, 10.1210/me.6.12.2160
Jensen, 1967, Sulfhydryl groups and estradiol-receptor interaction, Science, 158, 385, 10.1126/science.158.3799.385
Ratajczak, 1974, The protection, stabilization and reactivation of estradiol receptors in human myometrial cytosol, Biochim Biophys Acta, 338, 104, 10.1016/0304-4165(74)90340-7
Reese, 1991, Mutagenesis of cysteines in the hormone binding domain of the human estrogen receptor, J Biol Chem, 266, 10,880, 10.1016/S0021-9258(18)99101-5
Fersht, 1979, Cysteinyl-tRNA synthetase from Escherichia coli does not need an editing mechanism to reject serine and alanine, Biochemistry, 18, 1245, 10.1021/bi00574a020
Pakdel, 1992, Human estrogen receptor mutants with altered estrogen and antiestrogen discrimination, J Biol Chem, 267, 3429, 10.1016/S0021-9258(19)50749-9
Ekena, 1996, Identification of amino acids in the hormone-binding domain of the human estrogen receptor important in estrogen binding, J Biol Chem, 271, 20,053, 10.1074/jbc.271.33.20053
Hegy, 1996, Carboxymethylation of the human estrogen receptor ligand-binding domain-estradiol complex: HPLC/ESMS peptide mapping shows that cysteine 447 does not react with iodoacetic acid, Steroids, 61, 367, 10.1016/0039-128X(96)00042-6
Muldoon, 1980, Molecular and functional anomalies in the mechanism of the estrogenic action of 4-mercuri-17β-estradiol, J Biol Chem, 255, 1358, 10.1016/S0021-9258(19)86038-6
Puca, 1970, Binding activity of oestrogen receptors destroyed by iodination, Nature, 225, 1251, 10.1038/2251251a0
Baker, 1985, Diethyl pyrocarbonate, a histidine selective reagent, inhibits estrogen binding to receptor protein in rat uterus cytosol, Biochem Int, 11, 233
Borgna, 1988, Differential inhibition of estrogen and antiestrogen binding to the estrogen receptor by diethylpyrocarbonate, J Steroid Biochem, 31, 427, 10.1016/0022-4731(88)90311-1
Borgna, 1991, Differential interaction of estrogens and antiestrogens at the 17β-hydroxy or counterpart functions with the estrogen receptor, Eur J Biochem, 199, 575, 10.1111/j.1432-1033.1991.tb16157.x
Koffman, 1991, Evidence for involvement of tyrosine in estradiol binding by rat uterus receptor, J Steroid Biochem Molec Biol, 38, 135, 10.1016/0960-0760(91)90118-O
Shirley, 1992, Contribution of hydrogen bonding to the conformational stability of ribonuclease T1, Biochemistry, 31, 725, 10.1021/bi00118a013
Castoria, 1993, Properties of a purified estradiol-dependent calf uterus tyrosine kinase, Biochemistry, 32, 1740, 10.1021/bi00058a007
Arnold, 1995, Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by Src family tyrosine kinases in vitro, Mol Endocrin, 9, 24, 10.1210/me.9.1.24
Gantchev, 1994, Quantitative-structureactivity relationships/comparative molecular field analysis (QSAR/CoMFA) for receptor-binding properties of halogenated estradiol derivatives, J Med Chem, 37, 4164, 10.1021/jm00050a013
Sufrin, 1981, Steric mapping of the L-methionine binding site of ATP-L-methionine-S-adenosyltranferase, Molec Pharmacol, 19, 307
Kym, 1993, Molecular structures, conformation analysis, and preferential modes of binding of 3-aroyl-2-arylbenzo[b]thiophene estrogen receptor ligands: LY117018 and aryl azide photoaffinity labeling analogs, J Med Chem, 36, 3910, 10.1021/jm00076a020
Free, 1964, A mathematical contribution to structure-activity studies, J Med Chem, 7, 395, 10.1021/jm00334a001
Williams, 1977, Flexible drug molecules and dynamic receptors, Angew Chem Int Ed Eng, 16, 766, 10.1002/anie.197707661
Herron, 1986, Thermodynamic properties of ligand binding by monoclonal antifluorescyl antibodies, Biochemistry, 25, 4602, 10.1021/bi00364a022
Lewis, 1995, Molecular modeling of the human estrogen receptor and ligand interactions based on site-directed mutagenesis and amino acid sequence homology, J Steroid Biochem Molec Biol, 52, 55, 10.1016/0960-0760(94)00151-B
Lemesle-Varloot, 1992, A model for the determination of the 3D-spatial distribution of the functions of the hormone-binding domain of receptor that bind 3-keto-4-ene steroids, J Steroid Biochem Molec Biol, 41, 369, 10.1016/0960-0760(92)90363-N
Goldstein, 1993, Three-dimensional model for the hormone binding domains of steroid receptors, 90, 9949
Cheng, 1994, Analysis of the binding of 3,3′,5-triiodo-L-thyonine and its analogues to mutant human β1 thyroid hormone receptors: A model of the hormone binding site, Biochemistry, 33, 4319, 10.1021/bi00180a028